2024 — Scientists uncovered an overlooked mechanism in the gut immune system of patients suffering from severe cases of Crohn's disease. The discovery may help define how to treat patients with ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in ...

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

Unfortunately, IBD, as well as treatment, have both steadily increased in the last few years. Specifically, Crohn’s disease affects up to 300 people for every 100,000 in North America. Individuals of ...

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis ...

Fatigue in IBD 1 year after diagnosis does not appear to be less prevalent even when applying stricter definitions of disease ...

Risankizumab for Crohn disease taken over a long-term extension results in clinically meaningful sustained HRQOL improvements ...

Four years ago, over dinner and drinks, five Buckhead moms hatched a bold plan to turn their love of softball into a lifeline for those battling Crohn’s disease.